NO20022605L - Kjemiske fremgangsmåter og mellomprodukter - Google Patents

Kjemiske fremgangsmåter og mellomprodukter

Info

Publication number
NO20022605L
NO20022605L NO20022605A NO20022605A NO20022605L NO 20022605 L NO20022605 L NO 20022605L NO 20022605 A NO20022605 A NO 20022605A NO 20022605 A NO20022605 A NO 20022605A NO 20022605 L NO20022605 L NO 20022605L
Authority
NO
Norway
Prior art keywords
intermediates
chemical processes
chemical
processes
Prior art date
Application number
NO20022605A
Other languages
English (en)
Norwegian (no)
Other versions
NO20022605D0 (no
Inventor
Barry Michael Gravestock
Kenneth Edwin Herbert Warren
Simon David Ennis
Charlotte Angela Currie
Debra Ainge
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of NO20022605D0 publication Critical patent/NO20022605D0/no
Publication of NO20022605L publication Critical patent/NO20022605L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/06Phosphorus compounds without P—C bonds
    • C07F9/08Esters of oxyacids of phosphorus
    • C07F9/09Esters of phosphoric acids
    • C07F9/091Esters of phosphoric acids with hydroxyalkyl compounds with further substituents on alkyl
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6558Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system
    • C07F9/65583Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom containing at least two different or differently substituted hetero rings neither condensed among themselves nor condensed with a common carbocyclic ring or ring system each of the hetero rings containing nitrogen as ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6571Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and oxygen atoms as the only ring hetero atoms
    • C07F9/6574Esters of oxyacids of phosphorus
    • C07F9/65742Esters of oxyacids of phosphorus non-condensed with carbocyclic rings or heterocyclic rings or ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20022605A 1999-12-03 2002-05-31 Kjemiske fremgangsmåter og mellomprodukter NO20022605L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9928499.4A GB9928499D0 (en) 1999-12-03 1999-12-03 Chemical processes and intermediates
PCT/GB2000/004527 WO2001040236A2 (en) 1999-12-03 2000-11-28 Phosphorylation of terminal primary alcohol groups

Publications (2)

Publication Number Publication Date
NO20022605D0 NO20022605D0 (no) 2002-05-31
NO20022605L true NO20022605L (no) 2002-06-26

Family

ID=10865576

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022605A NO20022605L (no) 1999-12-03 2002-05-31 Kjemiske fremgangsmåter og mellomprodukter

Country Status (22)

Country Link
EP (1) EP1237895A2 (is)
JP (1) JP2003515539A (is)
KR (1) KR20020058072A (is)
CN (1) CN1433421A (is)
AR (1) AR026700A1 (is)
AU (1) AU762241B2 (is)
BG (1) BG106728A (is)
BR (1) BR0016087A (is)
CA (1) CA2395052A1 (is)
CO (1) CO5271712A1 (is)
CZ (1) CZ20021912A3 (is)
EE (1) EE200200282A (is)
GB (1) GB9928499D0 (is)
HU (1) HUP0204052A2 (is)
IL (1) IL149641A0 (is)
IS (1) IS6401A (is)
MX (1) MXPA02005396A (is)
NO (1) NO20022605L (is)
PL (1) PL364762A1 (is)
SK (1) SK7862002A3 (is)
WO (1) WO2001040236A2 (is)
ZA (1) ZA200203876B (is)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
GB0009803D0 (en) 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
GB0113297D0 (en) * 2001-06-01 2001-07-25 Astrazeneca Ab Chemical Process
SI1427711T1 (sl) 2001-09-11 2005-12-31 Astrazeneca Ab Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva
EP1443930A1 (en) 2001-10-25 2004-08-11 AstraZeneca AB Isoxazoline derivatives useful as antimicrobials
US7141588B2 (en) 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
CN1649866A (zh) 2002-02-28 2005-08-03 阿斯特拉曾尼卡有限公司 3-环状基-5-(含氮5-元环)甲基-噁唑烷酮衍生物及其作为抗菌药物的用途
CN1653064A (zh) 2002-02-28 2005-08-10 阿斯特拉曾尼卡有限公司 噁唑烷酮衍生物、其制备方法以及包含它们的药用组合物
DE60304360T2 (de) 2002-08-12 2006-11-16 Pharmacia & Upjohn Co. Llc, Kalamazoo N-aryl-2-oxazolidinone und deren derivate
TW200420573A (en) 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
ATE344036T1 (de) 2002-11-21 2006-11-15 Pharmacia & Upjohn Co Llc N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinon-5- carbonsäureamid-derivate und verwandte verbindungen als antibakterielle mittel
US8324398B2 (en) 2003-06-03 2012-12-04 Rib-X Pharmaceuticals, Inc. Process for the synthesis of biaryl oxazolidinones
EP1656370B1 (en) 2003-06-03 2012-08-15 Rib-X Pharmaceuticals, Inc. Biaryl heterocyclic compounds and methods of making and using the same
US7304050B2 (en) 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
AR046782A1 (es) 2003-12-17 2005-12-21 Rib X Pharmaceuticals Inc Compuestos heterociclicos de biarilo halogenados, composiciones farmaceuticas que los contienen, metodos para su elaboracion y su uso como medicamentos.
EP1723159B1 (en) 2004-02-27 2019-06-12 Melinta Therapeutics, Inc. Macrocyclic compounds and methods of making and using the same
JP5534497B2 (ja) 2005-06-08 2014-07-02 メリンタ セラピューティクス,インコーポレイテッド トリアゾール類の合成方法
EP2069339B1 (en) 2006-09-25 2011-05-18 Wockhardt Research Centre Substituted piperidinophenyl oxazolidinones
WO2014014845A1 (en) 2012-07-18 2014-01-23 Vertex Pharmaceuticals Incorporated Combination therapy comprising|1 -ethyl-3-[5-[2-{1 -hydroxy-1 -methyl-ethyl}pyrimidin-5-yl]-7-(tetra hydrofuran-2-|yl}-1 h-benzimidazol-2-yl]urea and derivatives thereof to treat mycobacterium|diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999064417A2 (en) * 1998-06-05 1999-12-16 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2001040236A3 (en) 2002-05-10
HUP0204052A2 (hu) 2003-03-28
EE200200282A (et) 2003-06-16
KR20020058072A (ko) 2002-07-12
SK7862002A3 (en) 2003-02-04
BG106728A (en) 2003-02-28
CO5271712A1 (es) 2003-04-30
CA2395052A1 (en) 2001-06-07
MXPA02005396A (es) 2002-11-29
WO2001040236A2 (en) 2001-06-07
AR026700A1 (es) 2003-02-26
CZ20021912A3 (cs) 2002-08-14
IL149641A0 (en) 2002-11-10
IS6401A (is) 2002-05-28
AU762241B2 (en) 2003-06-19
CN1433421A (zh) 2003-07-30
ZA200203876B (en) 2003-08-15
EP1237895A2 (en) 2002-09-11
PL364762A1 (en) 2004-12-13
AU1715601A (en) 2001-06-12
BR0016087A (pt) 2002-08-06
GB9928499D0 (en) 2000-02-02
JP2003515539A (ja) 2003-05-07
NO20022605D0 (no) 2002-05-31

Similar Documents

Publication Publication Date Title
DK1185536T3 (da) Hemisyntesefremgangsmåde og mellemprodukter deraf
NO20022605D0 (no) Kjemiske fremgangsmåter og mellomprodukter
DK1084289T4 (da) Fremgangsmåde og oplösningsmiddel til kemisk rensning
NO20016314L (no) Blandinger og fremgangsmåte for oljefeltapplikasjoner
DE60019547D1 (de) Biosensor
DE60018541D1 (de) Biosensor
EP1156325A4 (en) BIOSENSOR
EP1182450A4 (en) BIOSENSOR
NO20032753D0 (no) Forbindelse og anvendelse derav
NO20020765L (no) Kjemiske forbindelser
NO20042147L (no) Heterocykliske forbindelser og fremgangsmater for anvendelse derav
NO20021637D0 (no) Kjemiske forbindelser
NO20021449D0 (no) Substituerte 2-tio-3,5-dicyano-4-aryl-6-aminopyridiner og anvendelse derav
NO995660D0 (no) Fremgangsmåte ved kommunikasjon og anordning for samme
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
EP1412378A4 (en) APTAMERS AND ANTIAPTAMERS
DK1322597T3 (da) Fremgangsmåde og intermediære
DE60042953D1 (de) Oxidationsverfahren
PL363702A1 (en) Chemical process and new intermediates
NO990814L (no) Kjemiske forbindelser
GB9927302D0 (en) Chemical process and intermediates
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
ID29608A (id) Proses-proses kimia
NO20021498D0 (no) PRV-1-genet og anvendelsen av dette
IL136726A0 (en) Novel processes and intermediates

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application